AREAS OF EXCELLENCE
Immuno-oncology
With over 4,000 hematopoietic stem cell transplants performed, HMR is the largest transplant center in Quebec and one of the largest in Canada.
Blood and bone marrow cancers
Immuno-oncology encompasses blood and bone marrow cancers, which are among the most diagnosed cancers. HMR is a beacon in Quebec for the investigation and treatment of this type of cancer.
Regular researchers in immuno-oncology at the Centre de recherche de l’Hôpital Maisonneuve-Rosemont.
18
Patients treated in 2023
14 844
Patients treated in 2023
160
The University Institute of Hemato-Oncology and Cellular Therapy.
Maisonneuve-Rosemont Hospital (HMR) is a pioneer in cellular therapy and stem cell treatments. It was within its walls that the first stem cell transplant took place. Today designated as the University Institute of Hemato-Oncology and Cellular Therapy, HMR is recognized worldwide for this expertise and receives patients from all over Canada.
If immuno-oncology was one of the first fields where this expertise could be used, this domain now extends across all areas of excellence at HMR.
If immuno-oncology was one of the first fields where this expertise could be used, this domain now extends across all areas of excellence at HMR.
« The advancements in immuno-oncology and cellular therapy would not have been possible without the contribution of the FHMR. »
« Thanks to the Donors of the Foundation, we have been able to advance research and push the boundaries of science. The advancements in immuno-oncology and cellular therapy would not have been possible without the contribution of the FHMR. »
Dr. Denis-Claude Roy,Director of the University Institute of Hemato-Oncology and Cellular Therapy
Hôpital Maisonneuve-Rosemont
Anchored in the East since 1954, HMR is much more than a healthcare facility: it is a true institution at the heart of East Montreal and one of the largest hospital centers in Quebec. It provides care from birth to end-of-life for nearly 550,000 Montrealers.